CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinue production of Fluorognost HIV-1 IFA test kits routinely used for confirmation of HIV-1 antibody-reactive donations. Based on our current testing volume, CTS has sufficient HIV-1 IFA reagent inventory to continue performing this confirmatory test through the end of August 2019.
Check out the Communication page for the complete details on the updated IFA HIV-1 assay or by clicking the link: Communications
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...
On January 25, 2021, CTS implements the Ortho VIP viral marker testing platform. Conversion from the...
After a thorough and comprehensive review of proposals received from suppliers of viral marker testi...
CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...
CTS will be revising some forms in use by clients on October 26, 2020. We do try to limit form chang...